Document Status

This document has been corrected

Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

10.1186/s40425-019-0779-6

Published Online: 2019-12-?

Journal: Journal for ImmunoTherapy of Cancer•Publisher: BMJ

Authors: Chengcheng Li•Fan Zhang•Guoqiang Wang•Junling Li•Puyuan Xing•Shangli Cai•Shouzheng Wang•Yan Wang•Yiying Guo•Yu Xu

This document has been corrected

Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

10.1186/s40425-019-0779-6

Published Online: 2019-12-?

Journal: Journal for ImmunoTherapy of Cancer

Authors: Chengcheng Li•Fan Zhang•Guoqiang Wang•Junling Li•Puyuan Xing•Shangli Cai•Shouzheng Wang•Yan Wang•Yiying Guo•Yu Xu

NOW

2020-07-16•Correction

Correction: Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

10.1136/jitc-2020-0779-6corr1

* information provided by CrossRef

2020-07-16•Correction

10.1136/jitc-2020-0779-6corr1

* information provided by CrossRef

2019-12-?•Published